$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Does neuregulin-1 play a role in Type A behavior? The cardiovascular risk in young Finns study 원문보기

Behavioral and brain functions BBF, v.4, 2008년, pp.40 - 40  

Service, Helena M (Department of Psychology, University of Helsinki, Finland) ,  Hintsanen, Mirka (Department of Psychology, University of Helsinki, Finland) ,  Hintsa, Taina (Department of Psychology, University of Helsinki, Finland) ,  Lehtimäki, Terho (Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Finland) ,  Raitakari, Olli T (Department of Clinical Physiology, University of Turku, Finland) ,  Viikari, Jorma S (Department of Medicine, University of Turku, Finland) ,  Keltikangas-Järvinen, Liisa (Department of Psychology, University of Helsinki, Finland)

Abstract AI-Helper 아이콘AI-Helper

BackgroundNeuregulin-1 proteins are related to physiological correlates of Type A in terms of cardiac reactivity. Furthermore, neuregulin-1 gene (NRG1) may play a role in cardiovascular disease such as atherosclerosis and coronary heart disease i.e. the suggested "outcomes" of Type A behavior. There...

참고문헌 (25)

  1. Friedman M Rosenman RH Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence or arcus senilis, and clinical coronary artery disease J Am Med Assoc 1959 169 1286 1296 13630753 

  2. The review panel on coronary-prone behavior and coronary heart disease Coronary-prone behavior and coronary heart disease: a critical review Circulation 1981 63 1199 1215 7014026 

  3. Shekelle RB Hulley SB Neaton JD Billings JH Borhani NO Gerace TA Jacobs DR Lasser NL Mittlemark MB Stamler J The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease Am J Epidemiol 1985 122 559 570 4025299 

  4. Hemingway H Marmot M Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies BMJ 1999 318 1460 1467 10346775 

  5. Keltikangas-Järvinen L Hintsa T Kivimäki M Puttonen S Juonala M Viikari JS Raitakari OT Type A eagerness-energy across developmental periods predicts adulthood carotid intima-media thickness: the Cardiovascular Risk in Young Finns Study Arterioscler Thromb Vasc Biol 2007 27 1638 1644 17495237 10.1161/ATVBAHA.107.145524 

  6. Lemmens K Fransen P Sys SU Brutsaert DL De Keulenaer GW Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase Circulation 2004 109 324 326 14732742 10.1161/01.CIR.0000114521.88547.5E 

  7. Okoshi K Nakayama M Yan X Okoshi MP Schuldt AJ Marchionni MA Lorell BH Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion Circulation 2004 110 713 717 15289373 10.1161/01.CIR.0000138109.32748.80 

  8. Kahn JP Perumal AS Gully RJ Smith TM Cooper TB Klein DF Correlation of type A behaviour with adrenergic receptor density: implications for coronary artery disease pathogenesis Lancet 1987 2 937 939 2889863 10.1016/S0140-6736(87)91421-8 

  9. Le Mellédo JM Arthur H Dalton J Woo C Lipton N Bellavance F Koszycki D Boulenger JP Bradwejn J The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4 J Psychosom Res 2001 51 513 520 11602221 10.1016/S0022-3999(01)00190-8 

  10. Fukudo S Lane JD Anderson NB Kuhn CM Schanberg SM McCown N Muranaka M Suzuki J Williams RB Jr Accentuated vagal antagonism of beta-adrenergic effects on ventricular repolarization. Evidence of weaker antagonism in hostile type A men Circulation 1992 85 2045 2053 1317272 

  11. Panutsopulos D Arvanitis DL Tsatsanis C Papalambros E Sigala F Spandidos DA Expression of heregulin in human coronary atherosclerotic lesions J Vasc Res 2005 42 463 474 16155362 10.1159/000088100 

  12. Åkerblom HK Uhari M Pesonen E Dahl M Kaprio EA Nuutinen EM Pietikäinen M Salo MK Aromaa A Kannas L Keltikangas-Järvinen L Kuusela V Räsänen L Rönnemaa T Knip M Telama R Välimäki I Pyörälä K Viikari J Cardiovascular risk in young Finns Ann Med 1991 23 35 39 2036203 10.3109/07853899109147928 

  13. Livak KJ Allelic discrimination using fluorogenic probes and the 5' nuclease assay Genet Anal 1999 14 143 149 10084106 

  14. Stefansson H Sarginson J Kong A Yates P Steinthorsdottir V Gudfinnsson E Gunnarsdottir S Walker N Petursson H Crombie C Ingason A Gulcher JR Stefansson K St Clair D Association of neuregulin 1 with schizophrenia confirmed in a Scottish population Am J Hum Genet 2003 72 83 87 12478479 10.1086/345442 

  15. Haynes SG Levine S Scotch N Feinleib M Kannel WB The relationship of psychosocial factors to coronary heart disease in the Framingham study. I. Methods and risk factors Am J Epidemiol 1978 107 362 383 665654 

  16. Britsch S Li L Kirchhoff S Theuring F Brinkmann V Birchmeier C Riethmacher D The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system Genes Dev 1998 12 1825 1836 9637684 10.1101/gad.12.12.1825 

  17. Falls DL Neuregulins: functions, forms, and signaling strategies Exp Cell Res 2003 284 14 30 12648463 10.1016/S0014-4827(02)00102-7 

  18. Kamada T Miyake S Kumashiro M Monou H Inoue K Power spectral analysis of heart rate variability in Type As and Type Bs during mental workload Psychosom Med 1992 54 462 470 1502287 

  19. Evans PD Type A behaviour and coronary heart disease: when will the jury return? Br J Psychol 1990 81 147 157 2194626 

  20. Massion PB Feron O Dessy C Balligand JL Nitric oxide and cardiac function: ten years after, and continuing Circ Res 2003 93 388 398 12958142 10.1161/01.RES.0000088351.58510.21 

  21. Kawashima S Yokoyama M Dysfunction of endothelial nitric oxide synthase and atherosclerosis Arterioscler Thromb Vasc Biol 2004 24 998 1005 15001455 10.1161/01.ATV.0000125114.88079.96 

  22. Sparagon B Friedman M Breall WS Goodwin ML Fleischmann N Ghandour G Type A behavior and coronary atherosclerosis Atherosclerosis 2001 156 145 149 11369007 10.1016/S0021-9150(00)00604-3 

  23. Liu H Saijo Y Zhang X Shiraishi Y Luo Y Maruyama M Higa M Sekine K Yambe T Impact of type A behavior on brachial-ankle pulse wave velocity in Japanese Tohoku J Exp Med 2006 209 15 21 16636518 10.1620/tjem.209.15 

  24. Lee DJ King DW King LA Measurement of the Type A behavior pattern by self-report questionnaires: several perspectives on validity Educ Psychol Meas 1987 47 409 423 10.1177/0013164487472013 

  25. Pedersen NL Lichtenstein P Plomin R DeFaire U McClearn GE Matthews K Genetic and environmental influences for type A-like measures and related traits: a study of twins reared apart and twins reared together Psychosom Med 1989 51 428 440 2772107 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로